New sedative aims to get ICU patients off ventilators faster

NCT ID NCT07596589

First seen May 20, 2026

Summary

This study tests a sedative called remimazolam in 80 ICU patients who need a breathing machine. The goal is to see if it helps them spend more days off the ventilator and reduces complications like confusion. Participants are adults already on a ventilator for 1-4 days, and the study compares remimazolam to standard care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEDATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Zhongda Hospital

    RECRUITING

    Nanjing, Jiangsu, 210009, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.